Catalyst Wire Dossier Catalyst Wire Dossier

REMIFENTANIL HYDROCHLORIDE

REMIFENTANIL HYDROCHLORIDE · Hikma Pharmaceuticals USA Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for REMIFENTANIL HYDROCHLORIDE, covering 2018-01-16 to 2024-06-18. Get the full timeline:

Most recent: FDA Approved: REMIFENTANIL HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

See pricing